COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,804 Articles (22,527 medRxiv, 8,277 bioRxiv)

Most recent first Previous |  Page 1951: Articles 19501-19510  | Next

Extended in vitro inactivation of SARS-CoV-2 by titanium dioxide surface coating
Mlcochova, P., Chadha, A., Hesselhoj, T., Fraternali, F., Ramsden, J., Gupta, R. K.
10.1101/2020.12.08.415018 — Posted: 2020-12-08
Anti-SARS-CoV-2 activity of Andrographis paniculata extract and its major component Andrographolide in human lung epithelial cells and cytotoxicity evaluation in major organ cell representatives
Sa-ngiamsuntorn, K., Suksatu, A., Pewkliang, Y., Thongsri, P., Kanjanasirirat, P., Manopwisedjaroen, S., Charoensutthivarakul, S., Wongtrakoongate, P., Pitiporn, S., Khemawoot, P., Chutipongtanate, S., Borwornpinyo, S., Thitithanyanont, A., Hongeng, S.
10.1101/2020.12.08.415836 — Posted: 2020-12-08
Natural SARS-CoV-2 infections, including virus isolation, among serially tested cats and dogs in households with confirmed human COVID-19 cases in Texas, USA
Hamer, S. A., Pauvolid-Correa, A., Zecca, I. B., Davila, E., Auckland, L. D., Roundy, C. M., Tang, W., Torchetti, M. K., Killian, M. L., Jenkins-Moore, M., Mozingo, K., Akpalu, Y., Ghai, R. R., Spengler, J. R., Barton Behravesh, C., Fischer, R., Hamer, G. L.
10.1101/2020.12.08.416339 — Posted: 2020-12-08
Effect of COVID-19 response policies on walking behavior in US cities
Hunter, R. F., Garcia, L., de Sa, T. H., Zapata-Diomedi, B., Millett, C. J., Woodcock, J., Pentland, A., Moro, E.
10.1101/2020.12.07.20245282 — Posted: 2020-12-08
Optimizing SARS-CoV-2 molecular diagnostic using N gene target: insights about reinfection
Contelli Klein, R., Fabres Klein, M. H., Barbosa, L. G., Knnup, L. V. G., Venancio, L. P. R., Berlink Lima, J., Araujo-Santos, T.
10.1101/2020.12.06.20244905 — Posted: 2020-12-08
Single-cell RNA sequencing reveals in vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping'
Fischer, D. S., Ansari, M. I., Wagner, K., Jarosch, S., Huang, Y., Mayr, C. H., Strunz, M., Lang, N. J., D'Ippolito, E., Hammel, M., Mateyka, L., Weber, S., Wolff, L. S., Witter, K., Fernandez, I. E., Leuschner, G., Milger, K., Frankenberger, M., Nowak, L., Heinig, K., Koch, I., Stoleriu, M. G., Hilgendorff, A., Behr, J., Pichlmair, A., Schubert, B., Theis, F. J., Busch, D. H., Schiller, H. B., Schober, K.
10.1101/2020.12.07.20245274 — Posted: 2020-12-08
Seroprevalence of SARS-CoV-2 Antibodies in Seattle, Washington: October 2019-April 2020
McCulloch, D. J., Jackson, M. L., Hughes, J. P., Lester, S., Mills, L., Freeman, B., Rasheed, M. A. U., Thornburg, N. L., Chu, H. Y.
10.1101/2020.12.07.20244103 — Posted: 2020-12-08
Integrative analyses identify susceptibility genes underlying COVID-19 hospitalization
Pathak, G. A., Singh, K., Miller-Fleming, T. W., Wendt, F., Ehsan, N., Hou, K., Johnson, R., Lu, Z., Gopalan, S., Dimbou, L. Y., Mohammadi, P., Pasaniuc, B., Polimanti, R., Davis, L. K., Mancuso, N.
10.1101/2020.12.07.20245308 — Posted: 2020-12-08
Inadequate intention to receive Covid-19 vaccination: indicators for public health messaging needed to improve uptake in UK
Bachtiger, P., Adamson, A., Maclean, W. A., Quint, J. K., Peters, N. S.
10.1101/2020.12.07.20243881 — Posted: 2020-12-08
Model-based evaluation of school- and non-school-related measures to control the COVID-19 pandemic
Rozhnova, G., van Dorp, C. H., Bruijning-Verhagen, P., Bootsma, M. C. J., van de Wijgert, J. H. H. M., Bonten, M. J. M., Kretzschmar, M. E.
10.1101/2020.12.07.20245506 — Posted: 2020-12-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).